Analyst downgrades typically lead to a negative perception among investors, potentially causing a short-term decline in the stock price. The substantial reduction in the price target from $104 to $51 by a major financial institution like UBS suggests a significant change in the company's valuation, which could lead to a decrease in investor confidence and a drop in the stock price.